Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension
about
Immune and inflammatory mechanisms in pulmonary arterial hypertensionT lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapiesAssociation between circulating specific leukocyte types and blood pressure: the atherosclerosis risk in communities (ARIC) studyPerivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage.The sexual dimorphism associated with pulmonary hypertension corresponds to a fibrotic phenotypeCirculating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension.Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension.Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension.Relevant issues in the pathology and pathobiology of pulmonary hypertension.The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.Regulatory T cells and pulmonary hypertensionInflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.STAT3 signaling in pulmonary arterial hypertension.Complement components as potential therapeutic targets for asthma treatment.Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension.Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension.The cancer paradigm of severe pulmonary arterial hypertension.[Pulmonary arterial hypertension: a flavor of autoimmunity].Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension.The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension.Immune cells and autoantibodies in pulmonary arterial hypertension.Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension.Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension.Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities.Chronic intermittent hypobaric hypoxia attenuates monocrotaline-induced pulmonary arterial hypertension via modulating inflammation and suppressing NF-κB/p38 pathway.Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.Regulatory T Cells in Systemic SclerosisInflammation in Right Ventricular Failure: Does It Matter?Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
P2860
Q26851508-5DBF75F6-18C4-483C-A4B3-31B86F1201FDQ33679052-269CB96F-52DA-4C3A-AE50-5970D0A5385EQ33849207-DBF99E91-61D6-4CD1-A93F-67C9646DAFB6Q34460012-103C2426-5EF0-4594-A1EA-9A38CEAB07F4Q35173533-991AB334-4A1F-4E29-8D83-7574A3DFAE1CQ35517586-4E1A8055-8C5A-4B62-BC29-C46F9FC147A0Q35868734-A0B3A98B-6E4D-4A92-8042-2510BFFA5B33Q36190169-CABEF322-F9FF-453F-9343-15C73F06F6B5Q36973719-7965B2EA-FF55-4C64-AEAE-01E227A2E77DQ37673917-E4AE6FF5-6431-4F24-9FB4-6E06EC5AE8BDQ37851851-85D7A8F4-4FAC-48B0-B612-B8C467FC5EC1Q37905796-C9CE0CB9-68A9-4473-A7B7-B28C74B48FF1Q38027723-EC5C0CB3-726A-4419-BE13-ABC4542DB00EQ38111730-B36EA426-A4A6-4B71-921F-D2ED08A8A348Q38140894-7312D8C0-BAE5-455D-A3E7-5BED64114493Q38182225-28D6AB1A-6C50-42DF-87BB-89573E71C850Q38870144-89BCF027-1B74-4168-8D07-5061F7290637Q41393015-821D51F7-1890-459D-A810-47C4EE11AF92Q42682888-6477F808-6F33-4DF7-BDA2-552A6041295CQ43717280-9F80C879-AB43-493A-AF82-50541265B529Q44027694-F75DD310-1E0F-46FC-8FE7-D91166499065Q45046014-0EB438BB-2D5D-4229-A646-118699AEFD5DQ46175919-74FE5B90-BD04-4AAF-B47D-DFEBF0D498A8Q47742357-5D3B0F49-32F3-4755-8950-E529E8F215D5Q48140350-4B787873-1391-4DA4-A2A3-9A310771E6C3Q48261958-487DFA77-F149-42A3-9870-C1DD714E995FQ49600503-FBB88B73-1E8F-4AF9-BBDA-4F5A91CDDA0BQ51743683-87ED554D-B1EF-45BE-8AB0-16C1D5354905Q54425463-667A1C55-2C74-4718-942B-93583838A43DQ58122062-4E6CC74E-C13A-4AA0-9934-25F349EAFF6FQ58735426-AF538E99-FAE4-4EDC-8691-DDA9A0269030Q58800964-E94D5926-0A7C-4B4A-AF22-BE11A648D9E9
P2860
Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Increased regulatory and decre ...... ulmonary arterial hypertension
@ast
Increased regulatory and decre ...... ulmonary arterial hypertension
@en
Increased regulatory and decre ...... ulmonary arterial hypertension
@nl
type
label
Increased regulatory and decre ...... ulmonary arterial hypertension
@ast
Increased regulatory and decre ...... ulmonary arterial hypertension
@en
Increased regulatory and decre ...... ulmonary arterial hypertension
@nl
prefLabel
Increased regulatory and decre ...... ulmonary arterial hypertension
@ast
Increased regulatory and decre ...... ulmonary arterial hypertension
@en
Increased regulatory and decre ...... ulmonary arterial hypertension
@nl
P2093
P2860
P356
P1433
P1476
Increased regulatory and decre ...... ulmonary arterial hypertension
@en
P2093
Laima Taraseviciene
Mark R Nicolls
Norbert Voelkel
Rudolf Speich
Silvia Ulrich
P2860
P304
P356
10.1159/000111548
P577
2007-11-20T00:00:00Z